(MedPage Today) — The FDA approved nipocalimab (Imaavy) as the first treatment for warm autoimmune hemolytic anemia (wAIHA), the most common form of autoimmune hemolytic anemia.
Approval of the immunoselective neonatal Fc receptor (FcRn) blocker…
Source link
Ad Banner
Show Comments (0)
Hide Comments (0)
Subscribe
Login
0 Comments
Oldest
